AC Immune (ACIU) Interest Coverage Ratio Growth (3y) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 79.36% |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 29.25% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -16.86% |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.78% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 40.09% |
| 10 | AC Immune | 325.88 Mn | 211.53 Mn | - | 48.22% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 7.89% |
| Dec 31, 2025 | 73.63% |
| Sep 30, 2025 | 26.20% |
| Jun 30, 2025 | 35.00% |
| Mar 31, 2025 | 43.15% |
| Dec 31, 2024 | -153.35% |
| Sep 30, 2024 | -58.28% |
| Jun 30, 2024 | 88.18% |
| Mar 31, 2024 | -27.37% |
| Dec 31, 2023 | -44.07% |
| Sep 30, 2023 | 13.32% |
| Jun 30, 2023 | 31.11% |
| Mar 31, 2023 | -53.70% |
| Dec 31, 2022 | -203.03% |
| Sep 30, 2022 | 41.55% |
| Jun 30, 2022 | 75.19% |
| Mar 31, 2022 | 26.12% |
| Dec 31, 2021 | 0.43% |
| Sep 30, 2021 | -34.16% |
| Jun 30, 2021 | -43.97% |
| Mar 31, 2021 | 128.33% |
| Dec 31, 2020 | 698.33% |
| Sep 30, 2020 | 479.58% |
| Jun 30, 2020 | 254.78% |
| Mar 31, 2020 | 624.80% |
| Dec 31, 2019 | 108.40% |
| Sep 30, 2019 | -208.86% |
| Mar 31, 2019 | -131.46% |
| Dec 31, 2018 | -44.91% |
| Sep 30, 2018 | 45.44% |